5 unknown, 4 completed, 2 terminated, 1 active not recruiting. 14 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 14 | Unknown 5, Completed 4, Terminated 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Ischemic Stroke: new trials by email Literature Review of Ischemic Stroke trials Research Report on Ischemic Stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Preliminary Efficacy of NXL-001 in Patients With Ischemic Stroke intracerebral stereotactic injection of NXL-001 - Ischemic Stroke | Early Phase 1 | Recruiting | Beijing Tiantan Hospital | 9 | 2025-01-31 | 2026-09-09 |
| Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke Intra-arterial hypothermic magnesium sulfate infusion, Endovascular thrombectomy, Intravenous thrombolysis - Acute Ischemic Stroke | Early Phase 1 | Not yet recruiting | Capital Medical University | 6 | 2025-01-10 | 2025-01-07 |
| Intravenous Magnesium Sulphate in Acute Ischemic Stroke Magnesium Sulfate - Stroke, Ischemic Stroke | Early Phase 1 | Unknown | Dow University of Health Sciences | 44 | 2020-12-01 | 2020-06-02 |
| Blood PREssure Augmentation in Large-vessel Occlusion Stroke Study Phenylephrine, Norepinephrine - Ischemic Stroke, Blood Pressure | Early Phase 1 | Terminated | Yale University | 15 | 2020-09-11 | 2026-10-14 |
| A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke Induction of neural stem cells - Stroke, Ischemic | Early Phase 1 | Unknown | Allife Medical Science and Technology Co., Ltd. | 12 | 2019-03-01 | 2018-10-31 |
| A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke EPC treatment group - Stroke, Ischemic | Early Phase 1 | Unknown | Allife Medical Science and Technology Co., Ltd. | 12 | 2018-12-01 | 2018-11-01 |
| Hyperbaric Oxygen and Manipulative Therapies to Regain Function Post Stroke HBOT and OMT - Stroke, Motor Dysfunction | Early Phase 1 | Completed | Abington Memorial Hospital | 5 | 2018-02-03 | 2021-12-21 |
| Using SystemCHANGE™ to Enhance Medication Adherence in Older Adult Stroke Survivors SystemCHANGE™, Attention-Control - Stroke, Ischemic | Early Phase 1 | Completed | University of Missouri, Kansas City | 30 | 2017-11-28 | 2019-08-21 |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS Ferumoxytol, Tissue Analysis, Magnetic Resonance Imaging - Brain Injury, Central Nervous System Degenerative Disorder | Early Phase 1 | Completed | Michael Iv | 10 | 2015-06-10 | 2017-08-31 |
| Memantine for Enhanced Stroke Recovery Memantine XR, Placebo (for memantine) - Ischemic Stroke, Upper Extremity Weakness | Early Phase 1 | Active not recruiting | University of Utah | 20 | 2014-01-01 | 2026-08-27 |
| Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder LAmbre Left Atrial Appendage(LAA) Occluder - Atrial Fibrillation, Stroke | Early Phase 1 | Completed | Lifetech Scientific (Shenzhen) Co., Ltd. | 20 | 2012-10-01 | 2018-08-07 |
| Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor M5, C1-inhibitor - Acute Ischemic Stroke | Early Phase 1 | Terminated | TSI, LLC | 8 | 2012-09-01 | 2021-01-19 |
| Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke Atorvastatin, Placebo - Ventilator-associated Pneumonia, Ischemic Stroke | Early Phase 1 | Unknown | Shanghai Minhang Central Hospital | 100 | 2012-03-01 | 2013-02-26 |
| Lovaza's Effect on Clopidogrel in a Neuro Population omega-3 polyunsaturated fatty acids (Lovaza) - Ischemic Stroke, Transient Ischemic Attack | Early Phase 1 | Unknown | Millard Fillmore Gates Hospital | 60 | 2011-09-01 | 2012-02-06 |
Stroke (4) · Angioedemas, Hereditary (1) · Atrial Fibrillation (1) · Brain Infarction (1) · Brain Injuries (1) · Brain Ischemia (1) · Brain Neoplasms (1) · Cardiovascular Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Vascular Malformations (1) · Cerebral Infarction (1) · Cerebrovascular Disorders (1) · Hemorrhagic Stroke (1) · Ischemia (1)
Brain Diseases (14) · Central Nervous System Diseases (14) · Nervous System Diseases (14) · Cardiovascular Diseases (13) · Cerebrovascular Disorders (13) · Vascular Diseases (13) · Stroke (10) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Infections (2) · Signs and Symptoms (2) · Angioedema (1) · Arrhythmias, Cardiac (1) · Behavior (1)
Atorvastatin (1) · Complement C1 Inhibitor Protein (1) · Docosahexaenoic Acids (1) · Ferrosoferric Oxide (1) · Hyperbaric Oxygenation (1) · Magnesium Sulfate (1) · Magnetic Resonance Spectroscopy (1) · Memantine (1) · Norepinephrine (1) · Omacor (1) · Phenylephrine (1) · Sugars (1) · Tissue Array Analysis (1)
Allife Medical Science and Technology Co., Ltd. (2) · Abington Memorial Hospital (1) · Beijing Tiantan Hospital (1) · Capital Medical University (1) · Dow University of Health Sciences (1) · Lifetech Scientific (Shenzhen) Co., Ltd. (1) · Michael Iv (1) · Millard Fillmore Gates Hospital (1) · Shanghai Minhang Central Hospital (1) · TSI, LLC (1) · University of Missouri, Kansas City (1) · University of Utah (1) · Yale University (1)
United States (6) · China (4) · Netherlands (1)
Alicia Bennett, D.O. (1) · Congxin Huang, MD (1) · Cynthia L. Russell, Ph.D. (1) · Hana Choe, MD (1) · Jennifer L. Wessol, BSN (1) · Jennifer Majersik, M.D. (1) · Koos Burggraaf, MD, PhD (1) · Lan Hieu Nguyen, MD (1) · Liu ChunYan, MD (1) · Michael Iv, MD (1) · Muhammad Munawar, MD (1) · Nils H Petersen, MD, MSc (1) · Yan Yao, MD (1) · Yat-Yin YY Lam, MD (1)